Affordable Access

deepdyve-link
Publisher Website

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

Authors
  • Amaddeo, Giuliana1, 2, 3
  • Brustia, Raffaele4
  • Allaire, Manon5, 6
  • Lequoy, Marie7
  • Hollande, Clémence8
  • Regnault, Hélène1
  • Blaise, Lorraine9
  • Ganne-Carrié, Nathalie9, 10
  • Séror, Olivier10, 11, 12
  • Larrey, Edouard5, 6
  • Lim, Chetana13
  • Scatton, Olivier6, 13
  • El Mouhadi, Sanaa14
  • Ozenne, Violaine7
  • Paye, François15
  • Balladur, Pierre15
  • Dohan, Anthony16
  • Massault, Pierre-Philippe17
  • Pol, Stanislas8
  • Dioguardi Burgio, Marco11, 12
  • And 9 more
  • 1 Department of Hepatology, AP-HP, Hôpital Henri-Mondor, Créteil, France
  • 2 Paris Est Créteil University, UPEC, Créteil, France
  • 3 INSERM U955, Team “Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers”, Assistance Publique-Hôpitaux de Paris, Créteil, France
  • 4 Department of Digestive and Hepato-pancreatic-biliary Surgery, AP-HP, Hôpital Henri-Mondor, Créteil, France
  • 5 Hepatology and Liver Transplantation Department, Hôpital Pitié Salpêtrière, Sorbonne Université, AP-HP, Paris, France
  • 6 Sorbonne Université, Paris, France
  • 7 Department of Hepatology, AP-HP, Hôpital Saint Antoine, Paris, France
  • 8 Department of Hepatology, AP-HP, Hôpital Cochin, Paris, France
  • 9 Service d'Hépatologie, Hôpital Jean Verdier, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bondy, France
  • 10 Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris, INSERM UMR 1138 Functional Genomics of Solid Tumors Laboratory, Paris, France
  • 11 Department of Radiology, Hôpital Beaujon, Hôpitaux Universitaires Paris Nord Val de Seine, Assistance-Publique Hôpitaux de Paris, Clichy, France
  • 12 INSERM U1149 “Centre de Recherche sur l'Inflammation”, CRI, Paris, France
  • 13 Digestive and Liver Transplantation Department, Hôpital Pitié Salpêtrière, Sorbonne Université, AP-HP, Paris, France
  • 14 Department of Radiology, AP-HP, Hôpital Saint Antoine, Paris, France
  • 15 Department of Digestive Surgery, AP-HP, Hôpital Saint Antoine, Paris, France
  • 16 Department of Radiology, AP-HP, Hôpital Cochin, Université de Paris, Paris, France
  • 17 Department of Digestive Surgery, AP-HP, Hôpital Cochin, Université de Paris, Paris, France
  • 18 Digestive and Liver Transplantation Department, Hôpital Beaujon, Hôpitaux Universitaires Paris Nord Val de Seine, Assistance-Publique Hôpitaux de Paris, Clichy, France
  • 19 Department of Radiology, AP-HP, Hôpital Henri-Mondor, Créteil, France
  • 20 Département d'Oncologie Digestive, AP-HP, Hôpital Beaujon, Clichy, France
Type
Published Article
Journal
JHEP Reports
Publisher
Elsevier
Publication Date
Oct 31, 2020
Volume
3
Issue
1
Identifiers
DOI: 10.1016/j.jhepr.2020.100199
PMID: 33163949
PMCID: PMC7604130
Source
PubMed Central
Keywords
Disciplines
  • Research Article
License
Unknown

Abstract

• During the COVID-19 period, fewer patients with HCC presented to the multidisciplinary tumour board. • Globally, modification in the treatment strategy was observed in 13.1% of patients. • More than 21% of patients experienced a treatment delay >1 month in the COVID-19 period compared with 9.5% in 2019. • COVID-19 infection was the main reason for treatment delays in 2020. • In 2020, 7.1% of patients had a diagnosis of an active COVID-19 infection and 4/21 (19.1%) died.

Report this publication

Statistics

Seen <100 times